The predictive value of serum PAF-AH and Visinin-like protein 1 for poor prognosis in patients with hypertensive intracerebral hemorrhage
Serum PAF-AH and Visinin-like protein 1 in hypertensive intracerebral hemorrhage
Abstract
Objective To determine if serum levels of retinoid protein-like protein 1 (VILIP-1), Platelet-Activating Factor Acetylhydrolase (PAF-AH), and 8-hydroxydeoxyguanosine (8-OHDG) are prognostic of a poor prognosis in patients with hypertensive intracerebral hemorrhage.
Methods The 194 patients in the cerebral hemorrhage group were hospitalized for hypertensive cerebral hemorrhage between January 2022 and January 2024. Forty-five healthy individuals who underwent concurrent physical examinations at the hospital were selected to form the healthy control group. To observe the differences in the levels of serum PAF-AH, VILIP-1 and 8-OHDG, the relationship with the amount of intracerebral hemorrhage, the severity of intracerebral hemorrhage and poor prognosis, and how effectively it predicts the bad outcome of patients suffering from hypertensive intracerebral hemorrhage.
Results Serum PAF-AH, VILIP-1, and 8-OHDG levels were substantially greater in the brain hemorrhage group than in the healthy control group (P<0.05). The levels of serum PAF-AH, VILIP-1 and 8-OHDG in the cerebral hemorrhage group increased with the increase of the amount of cerebral hemorrhage and the severity of nerve defect, and patients with poor prognoses had significantly greater serum levels of PAF-AH, VILIP-1, and 8-OHDG than patients with excellent prognoses (P<0.05). The levels of serum PAF-AH, VILIP-1 and 8-OHDG have high value in predicting the poor prognosis of patients with cerebral hemorrhage. The combined detection's area under the curve (AUC) was 0.925, its sensitivity was 95.4%, and its specificity was 71.2%. The AUC of the three indicators found independently did not differ statistically significantly (P>0.05).
Conclusion PAF-AH, VILIP-1 and 8-OHDG are involved in the occurrence and development process of hypertensive intracerebral hemorrhage. The increase of their levels is related to poor prognosis. Combined detection is helpful to improve the predictive efficacy of poor prognosis in patients with hypertensive intracerebral hemorrhage.
References
2.Sullivan MN, Thakore P, Krishnan V, Alphonsa S, Li W, Feng Earley Y, Earley S. Endothelial cell TRPA1 activity exacerbates cerebral hemorrhage during severe hypertension. Front Mol Biosci. 2023 Jan 30;10:1129435. doi: 10.3389/fmolb.2023.1129435. PMID: 36793787; PMCID: PMC9922848.
3.Wong Zhang DE, Gibson Hughes TA, Figueiredo Galvao HB, Lo C, Dinh QN, Zhang SR, Kim HA, Selvaraji S, Clarkson AN, Arumugam TV, Drummond G, Sobey CG, De Silva TM. Post-stroke cognitive impairment and brain hemorrhage are augmented in hypertensive mice. J Cereb Blood Flow Metab. 2024 Dec;44(12):1517-1534. doi: 10.1177/0271678X241262127. Epub 2024 Jun 17. PMID: 38886874; PMCID: PMC11572097.
4.Zhang CY, Wang B, Hua XT, Fan K, Li YF. Serum vascular endothelial growth factor and cortisol expression to predict prognosis of patients with hypertensive cerebral hemorrhage. World J Clin Cases. 2023 Aug 16;11(23):5455-5461. doi: 10.12998/wjcc.v11.i23.5455. PMID: 37637696; PMCID: PMC10450374.
5.Sun H, Zhong Y, Liao L, Wu J, Xu H, Ma J. Obesity and hypertension mediate the effect of education on deep intracerebral hemorrhage: A Mendelian randomization study. J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107758. doi: 10.1016/j.jstrokecerebrovasdis.2024.107758. Epub 2024 May 4. PMID: 38710461.
6.Yamada SM, Tomita Y, Iwamoto N, Takeda R, Nakane M, Aso T, Takahashi M. Subcortical hemorrhage caused by cerebral amyloid angiopathy compared with hypertensive hemorrhage. Clin Neurol Neurosurg. 2024 Jan;236:108076. doi: 10.1016/j.clineuro.2023.108076. Epub 2023 Dec 1. PMID: 38128259.
7.Lei L, Qiao X, Siqi Y, Ke Y. Effects of Propofol Combined with Sufentanil Target-Controlled Intravenous Anesthesia on Expression of Bax, Bcl-2, and Caspase-3 Genes in Spontaneous Hypertensive Rats with Cerebral Hemorrhage: a Prospective Case-Controlled Study. Appl Biochem Biotechnol. 2023 Oct;195(10):6068-6080. doi: 10.1007/s12010-023-04378-0. Epub 2023 Feb 20. PMID: 36807871.
8.Chen CH, Cheng YW, Zhang R, Tezenas Du Montcel S, Guey S, Hervé D, Tang SC, Chabriat H. Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension? Stroke. 2025 Aug;56(8):2159-2166. doi: 10.1161/STROKEAHA.124.050484. Epub 2025 Apr 24. PMID: 40270244.
9.Li Q, Chen L. Effect of tibialis anterior muscle resistance training on ankle and foot dorsum extension function in hypertensive cerebral hemorrhage hemiplegia patients: A randomized controlled trial. Medicine (Baltimore). 2023 Aug 4;102(31):e33827. doi: 10.1097/MD.0000000000033827. PMID: 37543805; PMCID: PMC10403024.
10.Pu T, Zhong X, Jiang G, Wu Z, He S, Long Y, Liang Q, Tu X, Yao S, Wang J, He M. Association Between the Fetal-Type Posterior Cerebral Artery and Hypertensive Thalamic Hemorrhage. Brain Behav. 2024 Nov;14(11):e70147. doi: 10.1002/brb3.70147. PMID: 39508464; PMCID: PMC11541853.
11.Chen F, Zhang S, Li B, Zhang J, Ran M, Qi B. A review of invasive intracranial pressure monitoring following surgery for hypertensive cerebral hemorrhage. Front Neurol. 2023 Jul 4;14:1108722. doi: 10.3389/fneur.2023.1108722. PMID: 37470003; PMCID: PMC10353852.
12.Wu L, Li X, Yan J. Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma. Transl Oncol. 2024 Jul;45:101995. doi: 10.1016/j.tranon.2024.101995. Epub 2024 May 9. PMID: 38789241.
13.Zhang YZ, Zhang CY, Tian YN, Xiang Y, Wei JH. Cerebral arterial blood flow, attention, and executive and cognitive functions in depressed patients after acute hypertensive cerebral hemorrhage. World J Clin Cases. 2024 Jul 6;12(19):3815-3823. doi: 10.12998/wjcc.v12.i19.3815. PMID: 38994304; PMCID: PMC11235463.
14.Tjerkstra MA, Müller MCA, Coert BA, Hoefnagels FWA, Vergouwen MDI, van Vliet P, Ooms L, Rinkel GJE, Slooter AJC, Moojen WA, Jellema K, Vandertop WP, Verbaan D. Clinical response following hypertension induction for clinical delayed cerebral ischemia following subarachnoid hemorrhage: A retrospective, multicenter, cohort study. Eur J Neurol. 2023 Aug;30(8):2278-2287. doi: 10.1111/ene.15833. Epub 2023 May 28. PMID: 37151098.
15.Honda K, Goto K, Maeda M, Murata F, Fukuda H. Association Between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Patients With Hypertension: The LIFE Study. J Am Heart Assoc. 2025 Aug 19;14(16):e042523. doi: 10.1161/JAHA.125.042523. Epub 2025 Aug 6. PMID: 40767290.
16.Wu L, Chen X, Zeng Q, Lai Z, Fan Z, Ruan X, Li X, Yan J. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon. 2024 Mar 28;10(7):e28282. doi: 10.1016/j.heliyon.2024.e28282. PMID: 38601554; PMCID: PMC11004709.
17.Ozawa T, Suzuki H, Miyata T, Kameda T, Kobari T, Tetsuka M, Arai F, Ohtani K, Miyawaki T, Nagai M, Hashimoto M, Fujiwara T, Kario K, Kawai K, Fujimoto S, Tanaka R. Untreated and uncontrolled hypertension in Japanese patients with spontaneous intracerebral hemorrhage. Hypertens Res. 2025 Apr;48(4):1575-1585. doi: 10.1038/s41440-024-02087-7. Epub 2025 Jan 10. PMID: 39820067.
18.Zhang GJ, Wang H, Gao LC, Zhao JY, Zhang T, You C, Wang XY. Constructing and Validating a Nomogram for Survival in Patients without Hypertension in Hypertensive Intracerebral Hemorrhage-Related Locations. World Neurosurg. 2023 Apr;172:e256-e266. doi: 10.1016/j.wneu.2023.01.006. Epub 2023 Jan 7. PMID: 36627017.
19.Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel). 2024 Feb 12;12(2):186. doi: 10.3390/vaccines12020186. PMID: 38400169; PMCID: PMC10891594.
20.Das AS, Mallick A, Mora SA, Keins S, Abramson JR, Castello JP, Pasi M, Kourkoulis CE, Rodriguez-Torres A, Warren AD, Gökçal E, Viswanathan A, Greenberg SM, Anderson CD, Rosand J, Biffi A, Gurol ME. Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies. Neurol Sci. 2024 Oct;45(10):4913-4921. doi: 10.1007/s10072-024-07560-2. Epub 2024 May 21. PMID: 38772978.
21.Li Y, Lv M, Yu S, Zhang X, Zhao D. Efficacy of Quality Care on Maternal and Infant Outcomes in Patients with Hypertensive Disorders Complicating Pregnancy Complicated with Cerebral Hemorrhage. Altern Ther Health Med. 2024 Sep;30(9):234-240. PMID: 38290439.
22.Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting. 2024, 10(1), 1256. doi: 10.36922/ijb.1256.
23.Zhi T, Wang H, Wei X, Wei Z, Sun HT. Efficacy of neuroendoscopic and small-bone-window craniotomy microsurgery for hypertensive cerebral hemorrhage: a meta-analysis of Chinese RCT studies. Front Neurol. 2024 Aug 30;15:1434928. doi: 10.3389/fneur.2024.1434928. PMID: 39281412; PMCID: PMC11392835.
24.Jiang L, Tian J, Guo C, Zhang Y, Qian M, Wang X, Wang Z, Chen Y. Comparison of the efficacy of neuronavigation-assisted intracerebral hematoma puncture and drainage with neuroendoscopic hematoma removal in treatment of hypertensive cerebral hemorrhage. BMC Surg. 2024 Mar 12;24(1):86. doi: 10.1186/s12893-024-02378-3. PMID: 38475783; PMCID: PMC10935852.
25.Leppert J, Ditz C, Souayah N, Behrens C, Tronnier VM, Küchler J. Limitations of prone positioning in patients with aneurysmal subarachnoid hemorrhage and concomitant respiratory failure. Clin Neurol Neurosurg. 2023 Sep;232:107878. doi: 10.1016/j.clineuro.2023.107878. Epub 2023 Jul 5. PMID: 37423091.
26.Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs. 2022 Oct 1;33(9):943-959. doi: 10.1097/CAD.0000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295.
27.Wilkinson CM, Kalisvaart ACJ, Kung TFC, Abrahart AH, Khiabani E, Colbourne F. Tissue Compliance and Intracranial Pressure Responses to Large Intracerebral Hemorrhage in Young and Aged Spontaneously Hypertensive Rats. Hypertension. 2024 Jan;81(1):151-161. doi: 10.1161/HYPERTENSIONAHA.123.21628. Epub 2023 Nov 1. PMID: 37909235; PMCID: PMC10734784.
28.Healthcare Engineering JO. Retracted: Comparison of Clinical Efficacy of Sodium Nitroprusside and Urapidil in the Treatment of Acute Hypertensive Cerebral Hemorrhage. J Healthc Eng. 2023 Sep 20;2023:9807650. doi: 10.1155/2023/9807650. PMID: 37772023; PMCID: PMC10533249.
29.Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs. 2022 Jan 1;33(1):e590-e603. doi: 10.1097/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349.
30.Yuan Z, Wang Q, Sun Q, Li C, Xiong F, Li Z. Hypertensive intracerebral hemorrhage: Which one should we choose between laser navigation and 3D navigation mold? Front Surg. 2023 Feb 24;10:1040469. doi: 10.3389/fsurg.2023.1040469. PMID: 36911606; PMCID: PMC10001900.
31.Turnova P, Rudnay M, Bargerova S, Janosova S, Hatiar K, Martinaskova N, Krcho P, Dankovčík R. Cerebral artery reverse flow as an indicator of critical intracranial hypertension in fetal intracranial hemorrhage: Case report. Neuro Endocrinol Lett. 2023 Mar 8;44(1):1-4. PMID: 36931221.
32.Guo W, Meng L, Lin A, Lin Y, Fu Y, Chen W, Li S. Implication of Cerebral Small-Vessel Disease on Perihematomal Edema Progress in Patients With Hypertensive Intracerebral Hemorrhage. J Magn Reson Imaging. 2023 Jan;57(1):216-224. doi: 10.1002/jmri.28240. Epub 2022 Jun 24. PMID: 35749634.
33.Hou H, Li X. Clinical changes of serum melatonin and ICAM-1 levels in patients with basal ganglia hypertensive intracerebral hemorrhage. Pak J Med Sci. 2023 Jul-Aug;39(4):1024-1028. doi: 10.12669/pjms.39.4.7252. PMID: 37492282; PMCID: PMC10364252.
34.Guo M. Study on the Effects of Early Nasoenteric Tube Nutritional Support Assisted by Gastroscopy on Aspiration and Prognosis in Patients With Hypertensive Cerebral Hemorrhage. Neurologist. 2025 Aug 11. doi: 10.1097/NRL.0000000000000639. Epub ahead of print. PMID: 40791074.
35.Zhu H, Cha F, Guo T, Sang C. Outcomes, neurological function, and inflammation indices following minimally invasive hematoma removal in hypertensive cerebral hemorrhage patients. Am J Transl Res. 2025 Feb 25;17(2):1510-1521. doi: 10.62347/NQYU7306. PMID: 40092114; PMCID: PMC11909517.
Copyright (c) 2026 Yaqiang Bai, Man Wei, Zhikun Yang, Fanyan Bu, Ziyang Wang, Binfeng Zhu, Zuolei Zhu
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.